Utilities, Consumer...
Health Care: Health Services
IsoRay Inc. (ISR: AMEX)
$0.65 -0.06 | -8.45%
02/10/12 - 03:59 PM ET
24.65K / 72.80K
Vol / Avg. Vol:0.70 / 0.71
Open / Prev. Close:0.65 - 0.70
Today's Range:0.60 - 1.57
52 Wk Range:10.76%
Performance YTD:TheStreet Rating:
Portfolios with ISR
- Portfolio NameUser Type
- Userpatelbj Portfolio 1
- UserStock Ranger Portfolio 1
- UserPANTERA.GROUP 57
Latest ISR Headlines from TheStreet
- Biotech Sector Weekly Rewind 11.20.10 | 08:11 am
- Curis, PharmAthene: Midday Volume Plays 01.22.10 | 11:01 am
Press Releases for ISR
- IsoRay Applauds Cleveland Clinic Prostate Study Conclusions On Brachytherapy Superiority - Business Wire 02.07.12 | 08:02 am
- IsoRay, Inc. Investor Presentation Now Available For On-demand Viewing At RetailInvestorConferences.com - PR Newswire 12.05.11 | 10:12 am
- WestPark Capital, Inc., WestPark Capital, Announces $2.6 Million IsoRay Offering - PR Newswire 12.02.11 | 08:12 pm
- WestPark Capital Announces $2.6 Million IsoRay Offering - PR Newswire 12.02.11 | 07:12 pm
- IsoRay, Inc. To Webcast, Live, At RetailInvestorConferences.com On December 1st - PR Newswire 11.29.11 | 10:11 am
- IsoRay Ships First GliaSite® Brain Cancer Treatment - Business Wire 11.28.11 | 07:11 am
- IsoRay Receives Final Regulatory Approval For GliaSite® Brain Cancer Treatment - Business Wire 11.22.11 | 07:11 am
- IsoRay Announces Major International Distribution Agreement For GliaSite® - Business Wire 11.03.11 | 07:11 am
- MD Anderson Cancer Center Initiates Orders Of IsoRay's Cesium-131 For Intermediate Risk Prostate Cancer Study - Business Wire 10.10.11 | 07:10 am
- IsoRay, Inc. Reports Improved Performance In Fiscal Year 2011 - Business Wire 09.28.11 | 05:09 pm
Partner Headlines for ISR
- Isoray: Impressive 98% Success Treating Prostate Cancer - Seeking Alpha 11.17.11 | 09:11 am
- iCAD Q3 Results Impress: Shaping Up For A Strong 2012 - Seeking Alpha 10.30.11 | 09:10 am
- IsoRay's Cesium-131 Reaches Milestone - Analyst Blog - Zacks 10.06.11 | 05:10 pm
- Morning Market Movers - Benzinga 09.12.11 | 09:09 am
- Morning Market Movers - Benzinga 07.12.11 | 09:07 am
- IsoRay Sales Beats, Losses Trim - Analyst Blog - Zacks 05.18.11 | 10:05 am
